Hi Tech Biosciences India Profile
Key Indicators
- Authorised Capital ₹ 7.00 Cr
as on 15-12-2024
- Paid Up Capital ₹ 4.16 Cr
as on 15-12-2024
- Company Age 17 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 18.19 Cr
as on 15-12-2024
- Satisfied Charges ₹ 29.16 Cr
as on 15-12-2024
- Revenue 36.76%
(FY 2022)
- Profit 19.22%
(FY 2022)
- Ebitda 82.82%
(FY 2022)
- Net Worth 9.97%
(FY 2022)
- Total Assets 16.25%
(FY 2022)
About Hi Tech Biosciences India
The Corporate was formerly known as Hitech Bio Sciences India Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.00 Cr and a paid-up capital of Rs 4.16 Cr.
The company currently has active open charges totaling ₹18.19 Cr. The company has closed loans amounting to ₹29.16 Cr, as per Ministry of Corporate Affairs (MCA) records.
Shilpa Wagh and Raghavendra Gaikaiwari serve as directors at the Company.
- CIN/LLPIN
U24232PN2007PTC130033
- Company No.
130033
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Apr 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Hi Tech Biosciences India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raghavendra Gaikaiwari  | Managing Director | 24-Apr-2007 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shilpa Wagh | Whole-Time Director | 27-Oct-2012 | Current |
Financial Performance of Hi Tech Biosciences India.
Hi Tech Biosciences India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 36.76% increase. The company also saw a substantial improvement in profitability, with a 19.22% increase in profit. The company's net worth moved up by a moderate rise of 9.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hi Tech Biosciences India?
In 2023, Hi Tech Biosciences India had a promoter holding of 96.70% and a public holding of 3.30%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Hi Tech Biosynth Private LimitedActive 8 years 10 monthsShilpa Wagh and Raghavendra Gaikaiwari are mutual person
- Hi-Tech Bio LaboratoriesActive 23 years 5 months
Shilpa Wagh and Raghavendra Gaikaiwari are mutual person
- Sci - Molecules India Private LimitedActive 23 years 9 months
Shilpa Wagh and Raghavendra Gaikaiwari are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 13 Oct 2020 | ₹16.39 Cr | Open |
Axis Bank Limited Creation Date: 03 Oct 2019 | ₹0.43 M | Open |
Sidbi Creation Date: 20 Mar 2019 | ₹7.50 M | Open |
How Many Employees Work at Hi Tech Biosciences India?
Hi Tech Biosciences India has a workforce of 97 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hi Tech Biosciences India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hi Tech Biosciences India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
